• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXUSA
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/10/2023
Event Type  malfunction  
Event Description
The customer contacted mallinckrodt to report they experienced a photoactivation module leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported approximately 1500mls of whole blood was processed at the time the leak was observed.The customer stated the leak was coming from the photoactivation module during the reinfusion phase of the ecp treatment.The ecp treatment was aborted, and residual blood from the return bag was manually returned to the patient.The customer reported the patient was in stable condition.The customer returned the kit and smart card for evaluation.
 
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction photoactivation module leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot l348 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot l348 shows no trends.Trends were reviewed for complaint category photoactivation module leak.No trend was detected for this complaint category.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned kit and smart card is still in progress.A supplemental report will be filed when the analysis is complete (b)(4).N.S.(b)(6) 2023.
 
Manufacturer Narrative
A batch record review for kit lot l330 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot l330 shows no trends.The complaint kit and smart card were returned for evaluation.Review of the smart card data showed that the operator aborted the treatment during the reinfusion phase of the procedure.Examination of the returned kit found a crack in the photoactivation module.The crack runs along the outlet channel and across weld lines indicating the crack was not likely due to an insufficient weld.The photoactivation module was pressure tested and a leak was verified at the site of the crack.A break in the photoactivation module can occur if the photoactivation module is inadvertently damaged during storage, damaged during handling of the kit by the operator, or if there is a weakness in the photoactivation module material.The reported photoactivation module leak was confirmed; however, a definitive root cause for the photoactivation module leak could not be determined based on the available information.No further action is required at this time.This investigation is now complete.(b)(4).N.S.27-apr-2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
blanchardstown, dublin, D15 T X2V
EI  D15 TX2V
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
mark wendelken
440 route 22 east
suite 302
bridgewater, NJ 08807
MDR Report Key16683644
MDR Text Key313233162
Report Number3013428851-2023-00016
Device Sequence Number1
Product Code LNR
UDI-Device Identifier20705030200003
UDI-Public(01)20705030200003(10)L330(17)240501
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 04/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/01/2024
Device Catalogue NumberCLXUSA
Device Lot NumberL330
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/10/2023
Initial Date FDA Received04/05/2023
Supplement Dates Manufacturer Received04/21/2023
Supplement Dates FDA Received04/27/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/31/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age54 YR
Patient SexMale
Patient Weight54 KG
-
-